Exact Sciences Exact Sciences Continues M&A Strategy to Reach Further Into Cancer Dx Market Premium The company recently acquired PFS Genomics, which has developed a test to determine the necessity of radiotherapy for breast cancer patients. Exact Sciences Reports 16 Percent Q1 Revenues Rise, Acquires PFS Genomics for $30.6M The company said screening revenues, from Cologuard tests and Biomatrica products, rose 10 percent year over year during the quarter. Prostate Cancer Study Shows Oncotype DX GPS Test Accurately Measures Long-Term Outcomes Premium The 20-year study showed the test provided an accurate assessment of the risk of long-term metastases and mortality for patients with localized prostate cancer. Exact Sciences Sketches Out Strategy for End-to-End Cancer Testing With Ashion Acquisition Premium The company is getting ready to offer cancer patients every type of molecular cancer diagnostics, including testing for minimal residual disease. Exact Sciences Q4 Revenues up 58 Percent; Company to Acquire Ashion Analytics From TGen Exact's planned acquisition of Ashion, a sequencing lab based in Arizona, builds on the company's licensing of the TARDIS liquid biopsy technology from TGen in January. Jan 15, 2021 People in the News: Broad Institute's Eric Lander Named White House Science Advisor; More Jan 14, 2021 JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More Jan 11, 2021 Multi-Cancer Molecular Screening Assays Primed for Clinical Implementation in 2021 Premium Jan 11, 2021 Exact Sciences Reports Preliminary Q4 Revenues Up About 58 Percent Dec 28, 2020 M&A Deals in MDx/Omics Research Tools Space Fall 13 Percent in 2020 Premium Dec 10, 2020 Exact Sciences Oncotype DX Identifies Postmenopausal Breast Cancer Patients Who Can Forgo Chemo Premium Nov 17, 2020 Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition Nov 4, 2020 Biocartis to Invest in IVD Partnerships Following Termination of Genomic Health Deal Premium Oct 29, 2020 Biocartis, Exact Sciences Terminate Oncotype DX Agreement Oct 27, 2020 Exact Sciences Aiming to Make Pan-Cancer Blood Screening Part of Standard Medical Care Premium Oct 27, 2020 Exact Sciences to Acquire Thrive Earlier Detection for up to $2.15B; Q3 Revenues Spike 87 Percent Oct 15, 2020 Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests Oct 1, 2020 Amid Volatile Markets, GenomeWeb Index Up 3 Percent in September Sep 25, 2020 People in the News: New Appointments at Inivata, Exact Sciences, Euformatics, More Sep 24, 2020 Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test Sep 16, 2020 Startup Stitch Bio Bets on CRISPR Tech to Render Cancer Cells With Gene Fusions Druggable Premium Aug 28, 2020 XPrize Competition Hopes to Encourage 'Frequent, Fast, Cheap, and Easy' COVID-19 Testing Premium Jul 31, 2020 Exact Sciences Positions Itself as Cancer Testing Provider of Future as COVID Crisis Continues Premium Jul 30, 2020 Exact Sciences Q2 Revenues Up 35 Percent, Buoyed by COVID-19 Testing Sales Jun 30, 2020 Oncotype DX Predicts Outcomes in Men With Unfavorable Intermediate-Risk Prostate Cancer, Study Finds Premium Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.